CLINICAL_TRIALS
trial_result
· 2012-10-30
Clinical Trial Update: Efficacy and Safety of FTY720 in Patients With Relapsing Multiple Sclerosis [Phase 2]
Summary
Phase 2 trial update on efficacy and safety of FTY720 (fingolimod) in relapsing multiple sclerosis completed with results posted in 2012.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Novartis | Conditions: Multiple Sclerosis | Phase 2 | Status: COMPLETED | Results posted: 2012-10-30